In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Prescription Drug Fairness for 
Seniors Act of 2001''.

SEC. 2. FINDINGS AND PURPOSES.

    (a) Findings.--The Congress finds the following:
            (1) Manufacturers of prescription drugs engage in price 
        discrimination practices that compel many older Americans to 
        pay substantially more for prescription drugs than consumers in 
        foreign nations and the drug manufacturers' most favored U.S. 
        customers, such as health insurers, health maintenance 
        organizations, and the Federal Government.
            (2) Older Americans who buy their own prescription drugs 
        often pay twice as much for prescription drugs as consumers in 
        foreign nations and the drug manufacturers' most favored U.S. 
        customers. In some cases, older Americans pay 10 times more for 
        prescription drugs than such customers.
            (3) The discriminatory pricing by major drug manufacturers 
        sustains their high profits (for example, $27,300,000,000 in 
        1999), but causes financial hardship and impairs the health and 
        well-being of millions of older Americans. Many older Americans 
        are forced to choose between buying their food and buying their 
        medicines.
            (4) Foreign nations and U.S. federally funded health care 
        programs use purchasing power to obtain prescription drugs at 
        low prices. Medicare beneficiaries are denied this benefit and 
        cannot obtain their prescription drugs at the lower prices 
        available to such nations and programs.
            (5) Implementation of the policy set forth in this Act will 
        reduce prices for brand name prescription drugs for many 
        Medicare beneficiaries by an average of 40 percent.
            (6) In addition to substantially lowering the costs of 
        prescription drugs for older Americans, implementation of the 
        policy set forth in this Act will significantly improve the 
        health and well-being of older Americans and lower the costs to 
        the Federal taxpayer of the Medicare program.
            (7) Older Americans who are terminally ill and receiving 
        hospice care services represent some of the most vulnerable 
        individuals in our nation. Making prescription drugs available 
        to Medicare beneficiaries under the care of Medicare-certified 
        hospices will assist in extending the benefits of lower 
        prescription drug prices to those most vulnerable and in need.
    (b) Purpose.--The purpose of this Act is to protect Medicare 
beneficiaries from discriminatory pricing by drug manufacturers and to 
make prescription drugs available to Medicare beneficiaries at 
substantially reduced prices.

SEC. 3. PARTICIPATING MANUFACTURERS.

    (a) In General.--Each participating manufacturer of a covered 
outpatient drug shall make available for purchase by each pharmacy such 
covered outpatient drug in the amount described in subsection (b) at 
the price described in subsection (c).
    (b) Description of Amount of Drugs.--The amount of a covered 
outpatient drug that a participating manufacturer shall make available 
for purchase by a pharmacy is an amount equal to the aggregate amount 
of the covered outpatient drug sold or distributed by the pharmacy to 
Medicare beneficiaries.
    (c) Description of Price.--The price at which a participating 
manufacturer shall make a covered outpatient drug available for 
purchase by a pharmacy is a price no greater than the manufacturer's 
average foreign price.
    (d) Enforcement.--The United States shall debar a manufacturer of 
drugs or biologicals that does not comply with the provisions of this 
Act.

SEC. 4. SPECIAL PROVISION WITH RESPECT TO HOSPICE PROGRAMS.

    For purposes of determining the amount of a covered outpatient drug 
that a participating manufacturer shall make available for purchase by 
a pharmacy under section 3, there shall be included in the calculation 
of such amount the amount of the covered outpatient drug sold or 
distributed by a pharmacy to a hospice program. In calculating such 
amount, only amounts of the covered outpatient drug furnished to a 
Medicare beneficiary enrolled in the hospice program shall be included.

SEC. 5. ADMINISTRATION.

    The Secretary shall issue such regulations as may be necessary to 
implement this Act.

SEC. 6. REPORTS TO CONGRESS REGARDING EFFECTIVENESS OF ACT.

    (a) In General.--Not later than 2 years after the date of the 
enactment of this Act, and annually thereafter, the Secretary shall 
report to the Congress regarding the effectiveness of this Act in--
            (1) protecting Medicare beneficiaries from discriminatory 
        pricing by drug manufacturers, and
            (2) making prescription drugs available to Medicare 
        beneficiaries at substantially reduced prices.
    (b) Consultation.--In preparing such reports, the Secretary shall 
consult with public health experts, affected industries, organizations 
representing consumers and older Americans, and other interested 
persons.
    (c) Recommendations.--The Secretary shall include in such reports 
any recommendations the Secretary considers appropriate for changes in 
this Act to further reduce the cost of covered outpatient drugs to 
Medicare beneficiaries.

SEC. 7. DEFINITIONS.

    In this Act:
            (1) Average foreign price.--
                    (A) In general.--The term ``average foreign price'' 
                means, with respect to a covered outpatient drug, the 
                average price that the manufacturer of the drug 
                realizes on the sale of drugs with the same active 
                ingredient or ingredients that are consumed in covered 
                foreign nations, taking into account--
                            (i) any rebate, contract term or condition, 
                        or other arrangement (whether with the 
                        purchaser or other persons) that has the effect 
                        of reducing the amount realized by the 
                        manufacturer on the sale of the drugs; and
                            (ii) adjustments for any differences in 
                        dosage, formulation, or other relevant 
                        characteristics of the drugs.
                    (B) Exempt transactions.--The Secretary may, by 
                regulation, exempt from the calculation of the average 
                foreign price of a drug those prices realized by a 
                manufacturer in transactions that are entered into for 
                charitable purposes, for research purposes, or under 
                other unusual circumstances, if the Secretary 
                determines that the exemption is in the public interest 
                and is consistent with the purposes of this Act.
            (2) Covered foreign nation.--The term ``covered foreign 
        nation' means Canada, France, Germany, Italy, Japan, and the 
        United Kingdom.
            (3) Covered outpatient drug.--The term ``covered outpatient 
        drug'' has the meaning given that term in section 1927(k)(2) of 
        the Social Security Act (42 U.S.C. 1396r-8(k)(2)).
            (4) Debar.--The term ``debar'' means to exclude, pursuant 
        to established administrative procedures, from Government 
        contracting and subcontracting for a specified period of time 
        commensurate with the seriousness of the failure or offense or 
        the inadequacy of performance.
            (5) Hospice program.--The term ``hospice program'' has the 
        meaning given that term under section 1861(dd)(2) of the Social 
        Security Act (42 U.S.C. 1395x(dd)(2)).
            (6) Medicare beneficiary.--The term ``Medicare 
        beneficiary'' means an individual entitled to benefits under 
        part A of title XVIII of the Social Security Act or enrolled 
        under part B of such title, or both.
            (7) Participating manufacturer.--The term ``participating 
        manufacturer'' means any manufacturer of drugs or biologicals 
        that, on or after the date of the enactment of this Act, enters 
        into a contract or agreement with the United States for the 
        sale or distribution of covered outpatient drugs to the United 
        States.
            (8) Secretary.--The term ``Secretary'' means the Secretary 
        of Health and Human Services.

SEC. 8. EFFECTIVE DATE.

    The Secretary shall implement this Act as expeditiously as 
practicable and in a manner consistent with the obligations of the 
United States.
Prescription Drug Fairness for Seniors Act of 2001 - Requires each participating manufacturer of a covered outpatient drug to make it available for purchase by each pharmacy: (1) in an amount equal to the aggregate amount sold or distributed by the pharmacy to Medicare beneficiaries; and (2) at a price no greater than the manufacturer's average foreign price. Sets forth special provisions with respect to hospice programs.

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Muhammad Ali Commemorative Coin 
Act''.

SEC. 2. FINDINGS.

    Congress finds that--
            (1) Muhammad Ali was an Olympic gold medalist, 3-time World 
        Heavyweight Champion boxer, and one of the most celebrated and 
        well-known athletes in American history;
            (2) Muhammad Ali showed, beyond his impressive fighting 
        prowess in the boxing ring, even greater courage and tenacity 
        as an advocate outside the ring;
            (3) Muhammad Ali was a great philanthropist and a strong 
        champion of peace, equality, and freedom;
            (4) Muhammad Ali remains an icon of freedom of conscience;
            (5) Muhammad Ali was a prominent African American of the 
        Muslim faith, and was, and continues to be, a role model to the 
        citizens of the United States of all races, ethnicities, and 
        religions;
            (6) Muhammad Ali used his fame to advocate for humanitarian 
        causes in audiences with world leaders ranging from religious 
        leaders to heads of state; and
            (7) Muhammad Ali inspired people around the globe in 
        displaying the same vibrant and larger-than-life character and 
        dedication in spite of his physical ailments.

SEC. 3. COIN SPECIFICATIONS.

    (a) Denominations.--The Secretary of the Treasury (hereafter in 
this Act referred to as the ``Secretary'') shall mint and issue the 
following coins in commemoration of Muhammad Ali:
            (1) $5 gold coins.--Not more than 100,000 $5 coins, which 
        shall--
                    (A) weigh 8.359 grams;
                    (B) have a diameter of 0.850 inches; and
                    (C) contain 90 percent gold and 10 percent alloy.
            (2) $1 silver coins.--Not more than 350,000 $1 coins, which 
        shall--
                    (A) weigh 26.73 grams;
                    (B) have a diameter of 1.500 inches; and
                    (C) contain not less than 90 percent silver.
    (b) Legal Tender.--The coins minted under this Act shall be legal 
tender, as provided in section 5103 of title 31, United States Code.
    (c) Numismatic Items.--For purposes of section 5134 and 5136 of 
title 31, United States Code, all coins minted under this Act shall be 
considered to be numismatic items.

SEC. 4. DESIGN OF COINS.

    (a) Design Requirements.--
            (1) In general.--The design of the coins minted under this 
        Act shall be emblematic of the life and legacy of Muhammad Ali.
            (2) Design and inscriptions.--On each coin minted under 
        this Act there shall be--
                    (A) a designation of the value of the coin;
                    (B) an inscription of the year 2020; and
                    (C) inscriptions of the words ``Liberty'', ``In God 
                We Trust'', ``United States of America'', and ``E 
                Pluribus Unum''.
    (b) Selection.--The design for the coins minted under this Act 
shall be--
            (1) selected by the Secretary after consultation with the 
        Muhammad Ali Center; and
            (2) reviewed by the Citizens Coinage Advisory Committee.

SEC. 5. ISSUANCE OF COINS.

    (a) Quality of Coins.--Coins minted under this Act shall be issued 
in uncirculated and proof qualities.
    (b) Mint Facility.--Only 1 facility of the United States Mint may 
be used to strike any particular quality of the coins minted under this 
Act.
    (c) Period for Issuance.--The Secretary may issue coins minted 
under this Act only during the 1-year period beginning on January 1, 
2020.

SEC. 6. SALE OF COINS.

    (a) Sale Price.--The coins issued under this Act shall be sold by 
the Secretary at a price equal to the sum of--
            (1) the face value of the coins;
            (2) the surcharge provided in section 7(a) with respect to 
        such coins; and
            (3) the cost of designing and issuing the coins (including 
        labor, materials, dies, use of machinery, overhead expenses, 
        marketing, and shipping).
    (b) Bulk Sales.--The Secretary shall make bulk sales of the coins 
issued under this Act at a reasonable discount.
    (c) Prepaid Orders.--
            (1) In general.--The Secretary shall accept prepaid orders 
        for the coins minted under this Act before the issuance of such 
        coins.
            (2) Discount.--Sale prices with respect to prepaid orders 
        under paragraph (1) shall be at a reasonable discount.

SEC. 7. SURCHARGES.

    (a) In General.--All sales of coins issued under this Act shall 
include a surcharge of--
            (1) $35 per coin for the $5 coin; and
            (2) $10 per coin for the $1 coin.
    (b) Distribution.--Subject to section 5134(f)(1) of title 31, 
United States Code, all surcharges received by the Secretary from the 
sale of coins issued under this Act shall be promptly paid by the 
Secretary as follows:
            (1) Eighty percent of the surcharges shall be paid to the 
        Muhammad Ali Center in Louisville, Kentucky, to ensure growth 
        and innovation in museum programming to research, promote, and 
        educate on the legacy of Muhammad Ali.
            (2) Ten percent of the surcharges shall be paid to the 
        Muhammad Ali Institute for Peace and Justice at the University 
        of Louisville to advance the work, study and practice of 
        peacebuilding, social justice, and violence prevention through 
        the development of innovative educational programs, training, 
        service, and research.
            (3) Ten percent of the surcharges shall be paid to the 
        Muhammad Ali Parkinson Center (MAPC) and Movement Disorder 
        Clinic to continue serving as a resource for Parkinson's 
        disease patients and their families through the provision of 
        diagnosis, treatments, research, and education.
    (c) Audit.--The Comptroller General of the United States shall have 
the right to examine such books, records, documents, and other data of 
each of the organizations referred to in subsection (b) as may be 
related to the expenditures of amounts paid under that subsection.
    (d) Limitations.--Notwithstanding subsection (a), no surcharge may 
be included with respect to the issuance under this Act of any coin 
during a calendar year if, as of the time of such issuance, the 
issuance of such coin would result in the number of commemorative coin 
programs issued during such year to exceed the annual 2 commemorative 
coin program issuance limitation under section 5112(m)(1) of title 31, 
United States Code (as in effect on the date of the enactment of this 
Act). The Secretary of the Treasury may issue guidance to carry out 
this subsection.
Muhammad Ali Commemorative Coin Act This bill requires the Department of the Treasury to mint and issue commemorative coins that emblemize the life and legacy of Muhammad Ali.&nbsp; Surcharges received from the sale of these coins shall be paid to: (1) the Muhammad Ali Center in Louisville, Kentucky; (2) the Muhammad Ali Institute for Peace and Justice at the University of Louisville; and (3) the Muhammad Ali Parkinson Center and Movement Disorder Clinic.

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Helium Privatization Act of 1997''.

SEC. 2. AMENDMENT OF HELIUM ACT.

    Whenever in this Act an amendment or repeal is expressed in terms 
of an amendment to, or repeal of, a section or other provision, the 
reference shall be considered to be made to a section or other 
provision of the Helium Act (50 U.S.C. 167-167n), as amended by the 
Helium Privatization Act of 1996 (Public Law 104-273).

SEC. 3. DISPOSAL OF FACILITIES.

    Section 4 is amended by--
            (1) striking subsection (c); and
            (2) redesignating subsection (d) as subsection (c).

SEC. 4. SALE OF CRUDE HELIUM.

    Subsection 6(c) is amended by striking ``--'' and all that follows 
through ``(2)''.

SEC. 5. ELIMINATION OF STOCKPILE.

    Section 8 is amended to read as follows:

``SEC. 8. ELIMINATION OF STOCKPILE.

    ``(a) Secretary of Defense.--
            ``(1) In general.--Half of the helium reserves owned by the 
        United States on the date of the enactment of the Helium 
        Privatization Act of 1997 shall be placed under the authority 
        of the Secretary of Defense, who shall determine and execute 
        the storage, transportation, and use of helium from the 
        reserves. The Federal Government shall forgive any share of 
        debt owed on these reserves.
            ``(2) Location of reserves.--The Secretary of Defense may 
        maintain the reserves under the authority of the Secretary of 
        Defense at the site on which they are located on the date of 
        enactment of this Act, or transfer the reserves to another 
        site. In a case in which the Secretary of Defense elects to 
        transfer the reserves, the Secretary shall notify the Secretary 
        of the Interior of the transfer not later than the 
        predetermined date agreed to by the Secretary of Defense and 
        Secretary of the Interior.
    ``(b) Department of the Interior.--
            ``(1) In general.--The remaining half of the helium 
        reserves owned by the United States on the date of the 
        enactment of the Helium Privatization Act of 1997 shall remain 
        under the authority of the Secretary of the Interior.
            ``(2) Disposal of reserves.--
                    ``(A) Investment administrator.--In order to 
                dispose of the helium reserves under the authority of 
                the Secretary of the Interior, the Secretary of the 
                Interior shall appoint an Investment Administrator to 
                sell--
                            ``(i) the helium from the helium reserves; 
                        and
                            ``(ii) any production, refining, and 
                        marketing assets of the reserves, unless the 
                        Secretary of Defense determines that such 
                        assets are essential to the transportation or 
                        storage needs of the Secretary of Defense.
                The proceeds from any sales shall be paid to the 
                Treasury of the United States. A percentage of the 
                proceeds, as agreed to by the Secretary of the Interior 
                and the Investment Administrator, shall be used to pay 
                the salary of the Investment Administrator.
                    ``(B) Selection criteria for investment 
                administrator.--Any individual interested in the 
                position of Investment Administrator shall, within a 
                time period to be determined by the Secretary of the 
                Interior--
                            ``(i) submit in writing to the Secretary of 
                        the Interior a plan for disposing of the helium 
                        reserves under the authority of the Secretary 
                        of the Interior (including any unobligated 
                        natural gas reserves and real estate at the 
                        helium reserves used in helium refinement and 
                        production); and
                            ``(ii) make an oral presentation to the 
                        Secretary of the Interior on such plan.
                    ``(C) Interim disposal.--The Secretary of the 
                Interior may determine a price in consultation with the 
                helium industry, and sell helium described in paragraph 
                (1) during the period in which an Investment 
                Administrator has not been selected.
    ``(c) Discovery of Additional Reserves.--The discovery of 
additional helium reserves shall not affect the duties of the 
Secretaries to make sales of helium under this section.''.

SEC. 6. REPORT ON HELIUM.

    (a) National Academy of Sciences Report.--Subsection 15(a) is 
amended by inserting after ``disposal of helium reserves'' the 
following: ``under the authority of the Secretary of Defense''.
    (b) Report to Congress.--Subsection 15(b) is amended--
            (1) in paragraph (1) by inserting ``and'' after the 
        semicolon;
            (2) in paragraph (2) by striking ``; and'' and inserting a 
        period; and
            (3) by striking paragraph (3).

Helium Privatization Act of 1997 - Amends the Helium Act to repeal requirements for disposal of helium facilities.  Revises the formula for price determinations for crude helium sales to eliminate all factors but inflation adjustments. 
Revises stockpile elimination guidelines to mandate that half the Federal helium reserves be placed under the authority of the Secretary of Defense, who shall determine and implement helium storage, transportation, and use.  States that the Federal Government shall forgive any debt owed on such reserves.  Retains the remaining Federal helium under the authority of the Secretary of the Interior. Instructs such Secretary to appoint an Investment Administrator to sell the helium reserves and their attendant production, refining, and marketing assets unless the Secretary of Defense determines such assets are essential to Department of Defense transportation or storage needs.  Mandates payment of helium sales proceeds to the Treasury, with a percentage of such proceeds paid as salary to the Administrator pursuant to an agreement between the Administrator and the Secretary of the Interior. 
States that such Administrator shall be selected from individuals who submit and make an oral presentation of a written helium disposal plan (including any unobligated natural gas reserves and real estate used in helium refinement and production). 
Authorizes the Secretary of the Interior to determine a sales price in consultation with the helium industry, and to sell helium during the period in which no Investment Administrator has been selected. 
Declares that discovery of additional helium reserves shall not affect the duties of the Secretaries to make helium sales. 
Narrows solely to reserves under the authority of the Secretary of Defense the scope of a currently mandated National Academy of Sciences study on whether disposal of helium reserves will have a substantial adverse effect on U.S. scientific, technical, biomedical, or national security interests. 
Repeals the mandate that the Secretary of Defense make recommendations to the Congress on how to avoid potential adverse effects upon such U.S. interests by sales of crude helium reserves.